Previous close | 98.27 |
Open | 98.93 |
Bid | 96.84 x 1000 |
Ask | 96.90 x 900 |
Day's range | 95.71 - 99.32 |
52-week range | 51.04 - 107.80 |
Volume | |
Avg. volume | 1,144,029 |
Market cap | 9.611B |
Beta (5Y monthly) | 2.14 |
PE ratio (TTM) | 16.97 |
EPS (TTM) | 5.71 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 13 Mar 2000 |
1y target est | N/A |
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $102.18, denoting a +1.46% change from the preceding trading day.
Tenet Healthcare (THC) remains well-poised for growth on increased admissions and surgeries in the Hospital segment, acquisitions, debt repayment efforts and solid operating cash flows.
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?